Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Breast cancer receptor status: do results from a centralized pathology laboratory agree with SEER registry reports?

Ma H, Wang Y, Sullivan-Halley J, Weiss L, Burkman RT, Simon MS, Malone KE, Strom BL, Ursin G, Marchbanks PA, McDonald JA, Spirtas R, Press MF, Bernstein L.

Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2214-20. doi: 10.1158/1055-9965.EPI-09-0301.

2.

Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study.

Ma H, Wang Y, Sullivan-Halley J, Weiss L, Marchbanks PA, Spirtas R, Ursin G, Burkman RT, Simon MS, Malone KE, Strom BL, McDonald JA, Press MF, Bernstein L.

Cancer Res. 2010 Jan 15;70(2):575-87. doi: 10.1158/0008-5472.CAN-09-3460. Epub 2010 Jan 12.

3.

Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.

Ellingjord-Dale M, Vos L, Tretli S, Hofvind S, Dos-Santos-Silva I, Ursin G.

Breast Cancer Res. 2017 Jan 23;19(1):10. doi: 10.1186/s13058-016-0798-x.

5.

Breastfeeding and breast cancer risk by receptor status--a systematic review and meta-analysis.

Islami F, Liu Y, Jemal A, Zhou J, Weiderpass E, Colditz G, Boffetta P, Weiss M.

Ann Oncol. 2015 Dec;26(12):2398-407. doi: 10.1093/annonc/mdv379. Epub 2015 Oct 26. Review.

6.

Agreement of self-reported hormone receptor status with cancer registry data in young breast cancer patients.

McCarthy AM, McGuire E, Bristol M, Fredricks T, Domchek SM, Armstrong K.

Cancer Epidemiol. 2013 Oct;37(5):601-5. doi: 10.1016/j.canep.2013.05.010. Epub 2013 Jun 27.

7.

Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry.

Work ME, John EM, Andrulis IL, Knight JA, Liao Y, Mulligan AM, Southey MC, Giles GG, Dite GS, Apicella C, Hibshoosh H, Hopper JL, Terry MB.

Br J Cancer. 2014 Mar 4;110(5):1367-77. doi: 10.1038/bjc.2013.807. Epub 2014 Feb 18.

8.

Association between chronological change of reproductive factors and breast cancer risk defined by hormone receptor status: results from the Seoul Breast Cancer Study.

Chung S, Park SK, Sung H, Song N, Han W, Noh DY, Ahn SH, Yoo KY, Choi JY, Kang D.

Breast Cancer Res Treat. 2013 Aug;140(3):557-65. doi: 10.1007/s10549-013-2645-4. Epub 2013 Jul 31.

PMID:
23901017
9.

Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort.

Ma H, Henderson KD, Sullivan-Halley J, Duan L, Marshall SF, Ursin G, Horn-Ross PL, Largent J, Deapen DM, Lacey JV Jr, Bernstein L.

Breast Cancer Res. 2010;12(3):R35. doi: 10.1186/bcr2589. Epub 2010 Jun 18.

10.

US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.

Howlader N, Altekruse SF, Li CI, Chen VW, Clarke CA, Ries LA, Cronin KA.

J Natl Cancer Inst. 2014 Apr 28;106(5). pii: dju055. doi: 10.1093/jnci/dju055.

11.

Reproductive history and risk of three breast cancer subtypes defined by three biomarkers.

Phipps AI, Buist DS, Malone KE, Barlow WE, Porter PL, Kerlikowske K, Li CI.

Cancer Causes Control. 2011 Mar;22(3):399-405. doi: 10.1007/s10552-010-9709-0. Epub 2010 Dec 24.

12.

Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status.

Rusiecki JA, Holford TR, Zahm SH, Zheng T.

Cancer Detect Prev. 2005;29(5):419-26. Epub 2005 Sep 23.

PMID:
16185815
13.

Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study.

Ritte R, Tikk K, Lukanova A, Tjønneland A, Olsen A, Overvad K, Dossus L, Fournier A, Clavel-Chapelon F, Grote V, Boeing H, Aleksandrova K, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Berrino F, Mattiello A, Tumino R, Sacerdote C, Quirós JR, Buckland G, Molina-Montes E, Chirlaque MD, Ardanaz E, Amiano P, Bueno-de-Mesquita HB, van Gils CH, Peeters PH, Wareham N, Khaw KT, Key TJ, Travis RC, Weiderpass E, Dumeaux V, Lund E, Sund M, Andersson A, Romieu I, Rinaldi S, Vineis P, Merritt MA, Riboli E, Kaaks R.

BMC Cancer. 2013 Dec 9;13:584. doi: 10.1186/1471-2407-13-584.

14.

Breast feeding, parity and breast cancer subtypes in a Spanish cohort.

Redondo CM, Gago-Domínguez M, Ponte SM, Castelo ME, Jiang X, García AA, Fernández MP, Tomé MA, Fraga M, Gude F, Martínez ME, Garzón VM, Carracedo Á, Castelao JE.

PLoS One. 2012;7(7):e40543. doi: 10.1371/journal.pone.0040543. Epub 2012 Jul 11.

15.

Association of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the shanghai breast cancer study.

Bao PP, Shu XO, Gao YT, Zheng Y, Cai H, Deming SL, Ruan ZX, Su Y, Gu K, Lu W, Zheng W.

Am J Epidemiol. 2011 Sep 15;174(6):661-71. doi: 10.1093/aje/kwr145. Epub 2011 Jul 18.

16.

Association between family history of cancer and breast cancer defined by estrogen and progesterone receptor status.

Tutera AM, Sellers TA, Potter JD, Drinkard CR, Wiesner GL, Folsom AR.

Genet Epidemiol. 1996;13(2):207-21.

PMID:
8722747
17.

Parity and lactation in relation to estrogen receptor negative breast cancer in African American women.

Palmer JR, Boggs DA, Wise LA, Ambrosone CB, Adams-Campbell LL, Rosenberg L.

Cancer Epidemiol Biomarkers Prev. 2011 Sep;20(9):1883-91. doi: 10.1158/1055-9965.EPI-11-0465. Epub 2011 Aug 16.

18.

Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer.

Saltzman BS, Malone KE, McDougall JA, Daling JR, Li CI.

Breast Cancer Res Treat. 2012 Oct;135(3):849-55. doi: 10.1007/s10549-012-2183-5. Epub 2012 Aug 19.

19.

Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there?

Potter JD, Cerhan JR, Sellers TA, McGovern PG, Drinkard C, Kushi LR, Folsom AR.

Cancer Epidemiol Biomarkers Prev. 1995 Jun;4(4):319-26.

20.

Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status.

Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG.

Am J Epidemiol. 2000 Apr 1;151(7):703-14.

PMID:
10752798

Supplemental Content

Support Center